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Abstract: 
 KCNQ1 is a voltage-gated potassium channel that co-assembles with the KCNE 
family of transmembrane peptides.  KCNQ1/KCNE3 channels are found in colonic crypt 
and airway epithelial cells and are constitutively conducting at normal resting potentials. 
 Using site-directed mutagenesis, residues 87-96 in the C-terminus were mutated to 
alanine. The RNA of these mutants was microinjected into Xenopus oocytes and 
examined using a two-electrode voltage clamp. Results were compared to KCNE1 to 
determine the role of C-terminus in KCNQ1 modulation.
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 5 
1 Introduction 
  
 Voltage gated potassium channels (Kv channels) play important physiological 
roles in all forms of life.  Kv channels can repolarize cells, help maintain resting 
membrane potential or drive secretion of other ions such as sodium and chloride. Kv 
channels open and close in response to changes in membrane potential, thereby 
regulating the flow of potassium in and out of the cells (Voet, Biochemistry, 2004). 
 KCNQ1 is a Kv channel with six transmembrane helices, and one pore loop.   
KCNQ1 partners with a variety of subunits, including all five members of the KCNE 
family.  KCNE peptides are believed to have one transmembrane domain, with the N-
terminus on the extracellular side of the membrane, and the C-terminus on the 
intracellular side of the membrane.  KCNE peptides regulate gating kinetics and function 
of KCNQ1 channels, as well as other Kv channels, and account for the variety of currents 
observed in vivo (Robbins, 2001). 
 In the human heart, KCNQ1/KCNE1 complexes form the slow-activating outward  
IKS currents.  Mutations in KCNE1 and KCNQ1 lead to Long QT syndrome, which slows 
the repolarization of the heart and may led to deadly cardiac arryhthmia.  (Abbott and 
Goldstein, 2001) In colonic crypt cells, KCNQ1/KCNE3 complexes form a channel 
complex that is open at the large negative resting potentials of the cells, activates quickly 
and has a linear I/V relationship, unique from KCNQ1/KCNE1 complexes.  The 
KCNQ1/KCNE3 complex may play a role in driving chloride secretion (Schroeder et al, 
2000). 
 While the role of voltage-gated potassium channels is well understood, the 
protein-protein interactions that generate these roles are less well understood.  One 
method of identify protein-protein interactions is perturbation analysis. Perturbation 
analysis of potassium channels has proved useful in identifying structures and protein-
protein interfaces.  Comparison of electrophysiological data to that of wild-type channels 
will yield high impact and low impact amino acid residues; high impact residues may 
indicate protein-protein interactions (Hong and Miller, 2000; Li-Smerin et al, 2000).  
Similar methods can be employed to study structure and function of Kv channel subunits. 
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2 Background 
 Understanding the complex role potassium channels and their subunits play in 
human physiology is necessary for justifying further study of these proteins.  Much of the 
knowledge surrounding KCNQ1 and KCNE3 has come to light in recent years, and many 
questions are still left unanswered.  Comparisons to other voltage-gated potassium 
channels may aid in explanation of observed behavior of KCNQ1/KCNE3 complexes. 
 
2.1 Voltage Gated Potassium Channels 
Ion channels serve the role in cells of maintaining resting membrane potential.  
One type of ion channel, voltage gated channels, open or close in response to changes in 
the membrane potential of the cell.  Voltage gated potassium channels are a large family 
of proteins widely distributed in most forms of life (Abbott and Goldstein, 1998).  
Structurally, this family is characterized by a tetramer of subunits.  Each subunit contains 
one P-loop and six transmembrane (TM) domains.  Four P-loops surround a water-filled 
pore in the membrane, through which the potassium moves (Abbott and Goldstein, 1998).  
The six TM domains (called S1-S6) enclose the pore (See figure 1).  One TM domain, 
S4, contains five positively charged amino acid residues, which are thought to sense 
voltage changes (Voet, Biochemistry, 2004).   
 
Figure 1 - Basic structure of Kv subunits  
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 Kv channels in mammals are often found to have accessory subunits associated 
with them.  Cytoplasmic, peripheral and integral membrane proteins can all function as 
subunits that regulate, stabilize or inactivate Kv channels.  Integral membrane proteins 
typically assemble with the Kv channel to create native currents, therefore accounting for 
the diversity of kinetics observed with Kv channels (Abbott and Goldstein, 1998).  
 The crystal structure of a mammalian Kv channel, Kv1.2, was crystallized by 
Long, Campbell and MacKinnon (2005).  Kv1.2 was crystallized with a peripheral β 
subunit.  The structure showed four subunits of helices S1-S6 in a tetramer.  The S5 and 
S6 helices of one subunit overlap the S4-S5 linker of another subunit.  Within the ion 
conduction pore, on the S6 helix, the Pro-X-Pro sequence is conserved among Shaker-
family Kv channels, but is not seen in prokaryotic Kv channels.  In the crystal structure, 
the Pro-X-Pro sequence gives a kink to the S6 helix.  This shape is also seen in 
prokaryotic channels with a Gly residue and may play a role in ion selectivity (Long et al, 
2005) (See Figures 2A and 2B).     
 
Figure 2A and B - KcsA prokaryotic K channel side view and top view 
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2.2 KCNQ1 Voltage Gated Channel 
 The KCNQ family of Kv channels has six TMD and 1 P-loop domain.  KCNQ 
channels form both homotetramers and heterotetramers.  Mutations in members of the 
KCNQ family have been linked to  a variety of human diseases; some pharmacological 
chemicals have been shown to have particular affinity for individual members of the 
KCNQ family as well. (Robbins, 2001)  One member of this family, KCNQ1, has been 
found in many tissues, including cardiac muscle, skeletal muscle, intestinal cells and the 
ear (Abott and Goldstein, 1998; Schroeder et al, 2000).  In the heart, KCNQ1 assembles 
with five members of the KCNE family of subunits.  These subunits consist of one 
transmembrane domain (See Figure 1) and regulate the currents of KCNQ1, as well as 
other Kv channels. (McCrossan and Abbott, 2004).  In the human heart, KCNQ1 
assemblies with KCNE1, KCNE2 and KCNE3 are believed to create the IKS 
repolarization currents which are essential for normal cardiac function.  Mutations in 
KCNE1 have been linked to Long QT Syndrome and atrial fibrillation (Abbott and 
Goldstein, 1998), as well as deafness. 
 KCNQ1 homomers are sensitive to a variety of compounds.  
Tetraethylammonium (TEA), linopirdine, XE991, Chromonal 293B and Clofillium all 
inhibit KCNQ1 at a predictable level.  Assembly with KCNE peptides can alter 
pharmacology of the channels and can be used to study channel properties (Robbins, 
2001).   KCNQ1 channels also display inactivation which can be readily observed in high 
potassium solutions.  Seebohm et al (2003) claim that this inactivation is due to a “fast 
flickery process” between two different open states of the channel.  This same gating 
mechanism is proposed to influence conductance of rubidium, due to a larger pore size 
allowing Rb+ ions to pass as well as giving rise to Na+ block.  Assembly of KCNQ1 with 
KCNE peptides has been shown to alter inactivation and Rb+ conductance but not Na+ 
discrimination.  Because of this, Seebohm et al (2003) claim that KCNE peptides 
influence only one open state, which in turn effects the fast flickery movement between 
states in KCNQ1.  While this data suggests possible sites of interaction between KCNE 
peptides and KCNQ1, no definitive evidence has surfaced. 
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2.3 KCNQ1/KCNE3 Channels 
 KCNQ1/KCNE3 channels are found in human heart, as well as colonic crypt cells 
and airway epithelial cells (Schroeder et al, 2000).  KCNQ1 alone, as well as 
KCNQ1/KCNE1 channels would not be open at the negative resting potentials of these 
epithelial cells, however KCNQ1/KCNE3 channels would be open at this voltage.  The 
KCNQ1/KCNE3 channels produce characteristic currents that are almost instantaneously 
open upon stimulation and have a linear I/V ratio (Schroeder et al, 2000). Expression in 
Xenopus laevis oocytes of KCNQ1/KCNE3 reproduced the currents observed in the 
colonic cells (Schroeder et al).  KCNQ1/KCNE3 channels may be implicated in colonic 
chloride transport, because the channel removes K+ that was initially transported by the 
NaK2Cl channel, which in turn hyperpolarizes the cell, potentially stimulating the CFTR 
chloride transporter to open, so chloride ions can leave the cell.  Studies have shown that 
KCNQ1/KCNE3 channels may be cAMP-activated (Schroeder et al, 2000).  See Figure 3 
for peptide sequence of KCNE3. 
  Studies of KCNE1 and KCNE3 complexed with KCNQ1 done by Melman et al 
(2002) suggest that a triplet of amino acids are necessary for functional specificity.  
Moreso, the central amino acid—Thr58 in KCNE1 and Val72 in KCNE3—specifically 
controls the voltage gating properties (Melman et al, 2002).  Melman et al (2002) found 
that substitution of an aliphatic amino acid at the Thr-58 position in KCNE1 produced 
KCNE3-like currents.  Similarly, substitution of an amino acid with a hydroxyl group for 
the Val residue at position 72 in KCNE3 produces KCNE1-like currents.  This data 
suggests that the only amino acids necessary for modulation of KCNQ1 by KCNE1 or 
KCNE3 occur within the triplet (Melman et al, 2002).  However, this is contrary previous 
studies with KCNE1, where mutations near the COOH terminus are found to cause Long 
QT syndrome.   
 Gage and Kobertz (2004) proposed a bipartite model for modulation of KCNQ1 
by KCNE3.  Truncation mutants of the NH2 terminus, so long as they contained 
glycosylation sites, were sufficient to regulate KCNQ1 currents similar to wild-type 
(WT) KCNE3.  Truncation mutants of the COOH terminus exhibit similar characteristics 
to WT KCNE3, however inactivation, slow kinetics and lowered expression were 
observed.  Double truncation mutants, which essentially contained only the 
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transmembrane (TM) portion of KCNE3, exhibited similar characteristics to COOH 
terminus truncations.  Also, the COOH terminus mutation D90N—analogous to LQTS-
causing mutation in KCNE1 D76N—was masked by a functional TM domain.  
Additionally, chimeras of KCNE1 D76N and functional KCNE3 TM domain were also 
functional, however displayed slower kinetics as well as inactivation. Using chromanol 
293B, which blocks KCNQ1 and KCNQ1/KCNE3 at different concentrations, it was 
shown that COOH terminus truncation mutants allow some KCNQ1 to reach the cell 
membrane alone.  Gage and Kobetz’s data suggests that, while the TM domain is 
sufficient for channel regulation, the COOH terminus is important in trafficking.  In 
KCNE3, the TM domain is more active in modulation, and overrides the COOH terminus 
modulation of KCNQ1, however in KCNE1 the TM domain is passive, therefore COOH 
terminus modulation is apparent in such cases as D76N.   
 
METTNGTETWYESLHAVLKALNATLHSNLLCRPGPGLGPDNQTEERRASLPGRDDNSYMYILFVMFLFAVT
VGSLILGYTRSRKVDKRSDPYHVYIKNRVSMI 
Figure 3 - KCNE3 peptide sequence.  Green residues are nonpolar, cyan residues are 
polar, red residues are negatively charged, blue residues are positively charged, orange 
residues are helix breakers, black residues are histidine.  TM segment is underlined. 
 
2.4 Perturbation Analysis of Kv Channels 
 Perturbation analysis can be used to determine if a helical structure is present in a 
protein.  Mutant impact can be measured electrophysiologically and compared to WT 
data in order to determine high and low impact residues.   These residues are plotted on a 
helical wheel to determine if a pattern emerges.  Large, bulky residues—such as Trp—
will significantly alter channel function if that amino acid is in contact with any other part 
of the protein (Hong and Miller, 2000).  A study done on the S1 and S3 regions of a 
Shaker K+ channel employed the tryptophan-scanning method.  Each residue was 
individually mutated to Trp, then electrophysiological kinetics were measured, and a 
ΔΔG was determined.  From this data, “high” and “low” impact residues were determined 
and plotted on a helical wheel. Analysis of this data showed the S1 segment to have a 
helical pattern.  When a similar method was applied to the S3 region, only the first 14 
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residues showed a helical pattern; therefore, it is possible that the S3 region contains a 
helix as well as another structural motif (Hong and Miller, 2000).   
 Another possible method of perturbation analysis of Kv channels is through 
alanine scanning.  Alanine scanning can be considered less invasive or likely to cause 
improper folding compared to tryptophan scanning (Li-Smerin et al, 2000).  However, 
the principle is similar to tryptophan scanning, in that the small alanine residue will alter 
kinetics due to protein-protein interactions, and be relatively harmless at protein-water or 
protein-lipid interfaces.  An alanine scan of drk1 K+ channel S1-S4 segments revealed 
partial helical structures in all four segments, as well as small aqueous helical connecting 
loops (Li-Smerin et al, 2000).  The perturbation data corroborated hydrophobic and 
secondary structure predictions for the segments.  The recent high resolution structure of 
Kv1.2 (MacKinnon et al, 2005) validated the conclusions from perturbation analyses.   
 Because the KCNQ1/KCNE3 complex has known gating properties, a 
perturbation analysis of KCNE3 could be done in order to determine the structure of this 
subunit, as well as the portion of the peptide that interacts with KCNQ1.  Similarly, 
electrophysiological methods (see Figure 4) could be applied in order to explore the 
secondary structure of KCNE3.  Comparison of analogous residues in KCNE1 to those in 
KCNE3 may reveal important differences in KCNE3 and KCNE1 modulation of 
KCNQ1. 
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Figure 4 - Standard two electrode voltage clamp setup for oocyte recordings. 
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3. Materials and Methods 
3.1 Cloning the KCNE3 Gene 
 The human KCNE3 gene was cloned using polymerase chain reaction with 
HotStarTaq, KCNE3 primer and primer 5203. Using a MJ Research PTC-200 
thermocycler, the samples were heated for initial activation 15 minutes at 95*C, then 30 
cycles of denaturing 1 minute 94*C, annealing 1 minute 55*C and extension 1 minute 
72*C, with a final extension for 10 minutes 72*C.  Samples were stored at 4*C then 
purified on 1.5% agarose gel.  The insert band was cut out and purified using Qiagen 
QiaQuick PCR product purification system, then digested using HindIII and BglII (New 
England Bioscience) restriction enzymes.  Inserts were purified using QiaQuick system 
(Qiagen). The digested insert was ligated into the pSG01MX vector using T4 DNA 
Ligase (2,000,000 U).  XL Blue Supercompetant E. coli cells were transformed with the 
ligation mix and plated on LB agar plates containing either carbanicillian or ampicillian 
(1 mg/ml final concentration).  Plates were incubated overnight at 37*C.  Individual 
colonies were then isolated and incubated overnight in liquid cultures containing LB 
broth and carbanicillian or ampicillian on a shake table (225 RPM).  Liquid cultures were 
then centrifuged 10 minutes at 5000 RPM.  The pellet was resuspended in Sigma 
Miniprep Suspension Solution (Sigma).  The plasmid was isolated using Sigma Miniprep 
Kit (Sigma). NcoI test digests were performed to determine correct insertion and run on 
1% agarose gel, then sequence was determined by automated sequencing. 
 
3.2 KCNE3 Mutations 
 Mutations were introduced using a cloning cassette method employing two step 
PCR and mutagenic primers (See Table 1).  Custom primers were from Sigma Geno-Sys. 
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Table 1 - Mutagenic PCR primers for KCNE3.  The * indicates a silent mutation 
present in order to prevent primer dimer. 
 
The PCR protocol is as follows: 
PCR 1a: 
2 ng of KCNE3 template DNA was mixed with 50 uM of T7 primer, mutagenic primer 
“b” and TaqHotStart.  For mutant H93A, 6% DMSO was added.  
 
PCR 1b: 
2 ng of KCNE3 template DNA was mixed with 50 uM of 5203 primer, mutagenic primer 
“a” and TaqHotStart.  For mutant Y95A, 6% DMSO was added.  
Primer Name Sequence (5’ – 3’) 
K87Aa CTAGAAAAGTGGACGCGCGTAGTGACCCCTATC 
K87Ab GATAGGGGTCACTACGCGCGTCCACTTTTCTAG 
R88Aa CTAGAAAAGTGGACAAGGCTAGTGACCCCTATC 
R88Ab GATAGGGGTCACTAGCCTTGTCCACTTTTCTAG 
S89Aa GAAAAGTGGACAAGCGTGCTGACCCCTATCATGTG 
S89Ab CACATGATAGGGGTCAGCACGCTTGTCCACTTTTC 
D90Aa GTGGACAAGCGTAGTGCCCCCTATCATGTGTATATC 
D90Ab GATATACACATGATAGGGGGCACTACGCTTGTCCAC 
P91Aa GGACAAGCGTAGTGACGCCTATCATGTGTATATC 
P91Ab GATATACACATGATAGGCGTCACTACGCTTGACC 
Y92Aa TGGACAAGCGTAGTGACCCCGCTCATGTGTATATCAAGAAACG 
Y92Ab CGTTTCTTGATATACACATGAGCGGGGTCACTACGCTTGTCCA 
H93Aa CAGCGTAGTGACCCTTATGCTGTGTATATCAAGAAC 
H93Ab* GTTCTTGATATACACAGCATAAGGGTCACTACCGAC 
V94Aa GTGACCCCTATCATGCGTATATCAAGAACCGT 
V94Ab ACGGTTCTTGATATACGCATGATAGGGGTCAC 
Y95Aa GACCCCTATCATGTGGCTATCAAGAACCGTG 
Y95Ab CACGGTTCTTGATAGCCACATGATAGGGGTC 
I96Aa CCCCTATCATGTGTATGCCAAGAACCGTGTGT 
I96Ab ACACACGGTTCTTGGCATACACATGATAGGGG 
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PCR 1a and 1b were run for 15 minutes at 94°C, and 30 cycles total of 1 minute at 94°C, 
1 minute at 55°C, and 1 minute at 72°C, then 10 minutes at 72°C.  Samples were stored at 
4°C until further steps were taken.  For mutant H93A, annealing was preformed at 65°C.  
Samples were run on 2% agarose gel.  Samples were diluted 1:10 and 1:100 for use in 
PCR step 2. Diluted samples were mixed with 200 uM T7 primer and 200 uM 5203 
primer, and TaqHotStart.  The same heat cycle was used as in PCR 1a and 1b.  Samples 
were analyzed on 2% agarose gel, and bands were cut out and purified using Qiagen 
QiaQuick purification.  Digestion with HindIII and BglII, ligation, plasmid preparation 
and NcoI test digests were performed as with KCNE3 clones. 
 
3.3 In Vitro RNA Transcription 
 4-6 ng of KCNE3, KCNE3 mutants and KCNQ1 DNA was linearized using MluI 
(New England Biosciences) then extracted with 1:1 phenol:chloroform and precipitated at 
–80°C with ethanol.  RNA was transcribed using run off transcription with either T7 
Polymerase (KCNE3 and mutants) or SP6 Polymerase (KCNQ1).  RNA was extracted 
with 1:1 phenol:sevag and precipitated with isopropanol on ice.  RNA was resuspended 
in RNAse-free water, run on 1.5% agarose gel and stored at –80°C.   
 
3.4 Oocyte Extraction and RNA Injection 
 Oocytes were surgically removed from aenesthetized Xenopus laevis.  The oocyte 
sacs were mechanically separated using tweezers then incubated in OR2 (in mM: 8.25 
NaCl, 2 KCl, 1 MgCl2, 5 HEPES, pH 7.4 using NaOH) with 2 mg/ml collagenase type II 
(Worthington Biochemicals) for 75 minutes at room temperature.  Defolliculated oocytes 
were stored at 16°C in ND96 High Calcium (in mM: 96 NaCl, 2 KCl, 1.8 CaCl2, 1 
MgCl2, 5 HEPES, pH 7.6 using NaOH) with 50 µg/ml Gentamicin (Sigma Aldrich).   
 One day after removal, healthy oocytes were injected with RNA using a 
microinjector (See Figure 5). The ratios for KCNQ1: KCNE3 were empirically 
determined.  Oocytes were injected first with 7.5 ng KCNQ1 and 4.5 ng KCNE3 and 
mutants, then with 4.5 ng KCNQ1 and 6.5 ng KCNE3 and mutants.  Injected oocytes 
were stored at 16*C in ND96 High Calcium and 50 mg/ml Gentamicin for 2-5 days. 
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Figure 5 - Microinjection Setup 
 
3.5 Electrophysiological Recordings 
 Two to three days post injection, oocytes were selected for electrophysiology.  
Oocytes were voltage clamped using two-electrode voltage clamp setup (Axon 
Instruments DigiData 1322A and Warner 750C Oocyte clamp) at –80 mV in ND96 
Recording (In mM: 96 NaCl, 2 KCl, 0.3 CaCl2, 1 MgCl2, 5 HEPES, pH 7.6 with NaOH).  
Currents were recorded using Clampex9.2 program. Currents were elicited starting at –
100 mV, to +60 mV in steps of 20.  The interpulse interval was 20 seconds.  The oocytes 
were then bathed in KD98 (in mM: 98 KCl, 0.3 CaCl2, 1 MgCl2, 5 HEPES, pH 7.6 with 
NaOH) and currents were elicited from –100 mV to +80 mV in steps of 10.  Oocytes 
were then returned to ND96 solution, and currents were elicted at 0 mV, +20 mV, +60 
mV to confirm oocyte health. 
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3.6 Data Analysis 
 Tail currents were measured 3–6 ms after the capacitive transient using Axon 
Instruments Clampfit.  Using Microcal Origins Professional 6.0, currents were 
normalized to Imax.  An I/V curve was generated, and fitted using the Boltzmann 
Function: 
 y=A1+(A2–A1)/(1+exp((V– V1/2)(–0.0393*z))) 
∆G was calculated from the equation zVF, where z is the maximal slope, V1/2 is the 
midpoint of voltage-activation, and F is Faraday’s constant. 
∆∆G is generated by: 
 ∆G mutant–∆G WT 
Standard error of the measurement was also calculated. 
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4 Results 
4.1 KCNE3 Clones and Mutants 
 In order to carry out site-directed mutagenesis, it was first necessary to clone 
human KCNE3 into the pSG01MX plasmid, which is usable in both Xenopus oocytes and 
mammalian cell lines.  Once cloned into pSG01MX, KCNE3 was used as a template for 
cassette cloning.  See Figure 6.  PCR of KCNE3 yielded a band with a length of 
approximate 394 bases.  PCR 1a of the mutants yielded a band of approximately 300 
bases, and PCR 1b a band of approximately 100 bases.  See Figure 7.  PCR 2 yields a 
band of approximately 400 bases. After digestion, NcoI tests digests were performed.  
KCNE3 inserts were compared to pSG01MX with E1, while KCNE3 mutants were 
compared to wild type KCNE3 in pSG01MX. See Figure 8.  After a successful NcoI 
digest, mutants were confirmed by sequencing the cloning cassette at UMass Medical 
School Nucleic Acid Facility. 
Figure 6 - PCR schematic for mutagenesis.   
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Figure 7 - 1.5% agarose gel of PCR 1 of KCNE3 mutants.  Lanes from left to right: 
Marker; K87A 1a, 1b; R88A 1a, 1b; S89A 1a, 1b; D90A 1a, 1b; P91A 1a, 1b.  Similar 
data was obtained for mutants Y92A, V94A, Y95A and I96A. 
 
 
Figure 8 - NcoI test digest of mutagenized KCNE3 clones.  Lanes from left to right: 
Marker, WT E3 in pSG01MX, K87A, R88A, S89A, D90A, P91A, Y92A, V94A, Y95A, 
I96A. 
 
4.2 Electrophysiology and Ratio Optimization 
 Typically, ratios of RNA used in electrophysiology must be determined 
empirically.  Effectiveness of ratios can vary due to quality of RNA, precision of 
injection and general oocyte health.  In order to achieve ideal currents, ratios must be 
optimized for WT and each mutant for a given RNA.  Previous work (Gage and Kobertz, 
2005) provided guidelines for injection ratios.  In general, oocytes injected with 7.5 ng 
KCNQ1 RNA and 3.75 ng KCNE3 WT RNA yielded currents lower than expected for 
KCNQ1/KCNE3 complexes.  This is also generally true of the mutants R88A, S89A, 
D90A and V94A.  Resting potentials before clamping were generally between –70 and –
75 mV.  Upon visual inspection of the family of traces, in low potassium, an inactivation 
was seen at +40 mV and +60 mV, characteristic of KCNQ1 alone.  In addition, in high 
potassium, a KCNQ1 characteristic “hook” in the tail currents, also due to inactivation, 
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was clearly visible at higher voltages.  In typical KCNQ1/KCNE3 complexes these 
artifacts of inactivation are generally not seen.  This suggests that the currents observed at 
this ratio are due to assembly of KCNQ1 at sub-stoichiometric ratios of KCNE3 or 
presence of KCNQ1 channels without KCNE3. 
 Oocytes injected with 4.5 ng KCNQ1 RNA and 6.5 ng KCNE3 WT RNA 
exhibited currents at the level expected for KCNQ1/KCNE3 complexes.  Before 
clamping, resting potentials were generally between –80 and –90 mV. Mutants R88A and 
Y95A also had resting potentials in this area.  See Figure 9. 
 Mutants D90A, V94A and I96A were all injected at a ratio of 3 ng KCNQ1 RNA 
to 12 ng KCNE3 RNA.  This ratio led to resting potentials before clamping of greater 
than –75 mV, and currents that resembled WT KCNE3 currents.  See Figure 9.  Mutants 
S89A, P91A and Y92A did not generate current in enough oocytes to study, most likely 
due to poor RNA quality not the mutation itself. 
 
 
Figure 9 -  Electrophysiological recordings in KD98 (high potassium). The red line 
indicates 0 mV.  The pulse protocol is in the lower left column. 
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4.3 Data Analysis 
 Activation curves (normalized current vs. voltage) were generated for each 
mutant.  Shown in Figure 10 is the WT activation curve, and the activation curve for 
D90A.  Other activation curves were similar. After fitting the activation curves with a 
Boltzmann function, the data in Table 2 was generated.  
 
Figure 10 - Activation curves for WT and D90A. 
 
Table 2 - Data generated from activation curves. 
 z (charge) V1/2 (mV) ∆G (kcal/mol) ∆∆G (kcal/mol) 
Wild Type (n=7) 1.05±0.12 –19.3±2.0 –0.47±0.07  
R88A (n=5) 0.92±0.09 –15.3±8.2 –0.33±0.17 0.14±0.19 
D90A (n=3) 1.31±0.03 –27.2±2.1 –0.83±0.06 –0.36±0.09 
V94A (n=3) 1.05±0.01 –28.0±4.2 –0.68±0.10 –0.21±0.12 
Y95A (n=2) 1.36±0.22 –28.2±1.3 –0.88±0.15 –0.42±0.17 
I96A (n=4) 1.09±0.06 –13.0±1.0 –0.33±0.03 0.14±0.07 
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5 Discussion  
 Based on the data generated from the recordings and shown in Table 2, this region 
of the C-terminus does not impact modulation of KCNQ1 by KCNE3.  Former work 
(Hong and Miller, 2000; J. Rocheleau, unpublished data) has shown that a ΔΔG of greater 
magnitude than 1 kcal/mol is indicative of a high impact residue; none of the mutants 
tested here generated a ΔΔG greater than 0.42 kcal/mol.  Therefore, based on the small 
sample of C-terminus mutants studied, it appears that the C-terminus of KCNE3 does not 
impact modulation, in accordance with the previous truncation studies done by Gage and 
Kobertz (2004).   
 Of particular interest is mutant D90A.  The analogous mutation in KCNE1 has 
been shown to generate non-functional complexes (Gage and Kobertz, 2004).  However, 
this mutation in KCNE3 appears to not effect complex functionality in any significant 
way.  The activation curve is slightly left-shifted, possibly due to presence of KCNQ1 
channels without KCNE3; however, D90A is still a low-impact residue. This indicates 
that the C-terminus represents an area of significant difference in modulation between 
KCNE1 and KCNE3, despite amino acid conservation. 
 Further work is necessary in order to fully understand KCNE3 modulation of 
KCNQ1.  Additional recordings of the mutants examined in this study would be 
beneficial in order to confirm statistical significance of the data.  A tryptophan scan of the 
transmembrane region may provide insight into membrane-bound protein-protein 
interactions that effect modulation.  Comparing data from KCNE3 perturbation analysis 
to that of KCNE1 may reveal important differences in modulation of these two related 
proteins.
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